Cell and gene therapy investment, once booming, is now in a slump
BioPharma Drive: Drug Pricing
AUGUST 29, 2024
Far fewer venture funding rounds were closed by cell and gene therapy developers over the first six months of 2024 than in prior years. Experts say there are several factors.
Let's personalize your content